IOL PMA supplements
This article was originally published in The Gray Sheet
Executive Summary
ODE's Division of Ophthalmic Devices has trimmed by more than half the seventy-plus backlog of premarket approval application supplements for intraocular lenses that were pending at the division in July, staffers report